Stocks · Real Estate · REIT - Healthcare Facilities
Ventas, Inc. VTR
$84.01 +0.33% Close, Oct 2, 2026 · NYSE · Market cap $40.84B
Strong growth
Next earnings report: Oct 27, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Net debt is 5.4× EBITDA, a high level of leverage.
- Revenue over the last four quarters was $6.44B, up 21.5% from a year earlier.
- Diluted EPS over the last four quarters was $0.54, up 23.9% year over year.
PromtFinance scores
Each score is a percentile within the Real Estate sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth90Exceptional
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 21%
- EPS growth (TTM, YoY)Top 39%
- FCF growth (TTM, YoY)Top 25%
- Revenue growth, 3-year CAGRTop 22%
- Revenue growth accelerationTop 41%
Quality63Neutral
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 12%
- Gross marginBottom 11%
- Operating marginBottom 29%
- Cash conversion (OCF / net income)Top 13%
- Accruals (lower is better)Top 25%
- Net debt / EBITDA (lower is better)Top 45%
- Interest coverBottom 41%
Value27Very weak
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 33%
- Free-cash-flow yieldBottom 38%
- EBITDA / enterprise valueBottom 29%
- Sales / enterprise valueTop 45%
- P/E vs own 5-year history (lower is better)Bottom 40%
Momentum77Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 13%
- 6-month returnTop 39%
- 1-year return vs S&P 500Top 14%
- Distance from 52-week highTop 37%
- Trend checklist (0–4)Top 41%
Revisions40Weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 32%
- Consecutive EPS beatsBottom 18%
- Share of analysts rating BuyTop 35%
- Upside to consensus price targetBottom 39%
Stability77Positive
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 43%
- Maximum drawdown, 3 yearsTop 8%
- Beta vs S&P 500 (lower is better)Top 14%
- Net debt / EBITDA (lower is better)Top 45%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 20.7% | 21.5% | ↑ |
| EPS growth (YoY) | 65.2% | 23.9% | ↓ |
| Gross margin | 42.1% | -2.6% | ↓ |
| Operating margin | 14.7% | 12.9% | ↓ |
| FCF margin | 23.4% | 24.9% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 21.5% | 20.7% | ↑ | Top 21% |
| EPS growth (TTM, YoY) | 23.9% | 65.2% | ↓ | Top 39% |
| Gross margin | -2.6% | 42.1% | ↓ | Bottom 11% |
| Operating margin | 12.9% | 14.7% | ↓ | Bottom 29% |
| Net margin | 4.1% | 3.6% | ↑ | — |
| Free-cash-flow margin | 24.9% | 23.4% | ↑ | — |
| Return on invested capital | 22.3% | — | Top 12% | |
| Revenue growth, 3-year CAGR | 12.2% | — | Top 22% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +47.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 5.39×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.27%
- Net buyback yield (TTM)
- -9.61%
- Shareholder yield
- -7.34%
- Share count change, 1 year
- +7.2%
- Share count change, 3-year CAGR
- +6.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +22.3%
- Average 2-day reaction, last 8
- +0.7%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $99.93
- Target vs current price
- +19.0%
- Analysts with a rating
- 32
- Share rating Buy or Strong Buy
- 56%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | -1.6% | -0.4% | -7.4% | -4.4% | — |
| Apr 27, 2026 | -10.5% | +1.3% | +5.3% | +5.5% | +16.2% |
| Feb 5, 2026 | +49.0% | +2.7% | +10.2% | +9.3% | +13.2% |
| Oct 29, 2025 | +52.2% | -0.4% | +7.0% | +13.4% | +8.9% |
| Jul 30, 2025 | -82.4% | -0.5% | +2.8% | +1.2% | +5.4% |
| Apr 30, 2025 | -86.6% | +1.4% | -4.8% | -6.9% | -3.9% |
| Feb 12, 2025 | +105.3% | +0.6% | +12.4% | +11.4% | +10.1% |
| Oct 30, 2024 | +0.0% | +0.7% | -2.4% | -2.7% | -7.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $0.14 | $0.14 | -1.6% | $1.73B |
| Apr 27, 2026 | $0.11 | $0.12 | -10.5% | $1.66B |
| Feb 5, 2026 | $0.15 | $0.10 | +49.0% | $1.57B |
| Oct 29, 2025 | $0.14 | $0.09 | +52.2% | $1.49B |
| Jul 30, 2025 | $0.15 | $0.85 | -82.4% | $1.42B |
| Apr 30, 2025 | $0.11 | $0.82 | -86.6% | $1.36B |
| Feb 12, 2025 | $0.13 | $0.06 | +105.3% | $1.29B |
| Oct 30, 2024 | $0.80 | $0.80 | +0.0% | $1.24B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 155.6× | 164.7× | 43th | Bottom 33% |
| P/E (forward) | 144.1× | — | — | — |
| EV / EBITDA | 21.7× | — | — | Bottom 29% |
| EV / Sales | 8.43× | — | — | Top 45% |
| Free-cash-flow yield | 3.93% | — | — | Bottom 38% |
| Earnings yield | 0.64% | — | — | Bottom 33% |
P/E over the past five years
Range 101.8× – 370.2× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +19.5%
- Earnings per share growth (TTM)
- +23.9%
- Change in P/E multiple
- +10.4%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -2.2%
- 200-day average slope (20 days)
- +0.9%
- Distance from 50-day average
- -7.4%
- Distance from 200-day average
- -2.2%
- RSI (14)
- 27.3
- Relative volume
- 0.78×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 24.9%
- Volatility vs own 5-year history
- 43th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.20
- Correlation with S&P 500
- 0.15
- Current drawdown from 1-year high
- -16.4%
- Maximum drawdown, 3 years
- -18.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 29, 2022 | Oct 14, 2022 | -43.4% | 138 days | 476 days (Sep 9, 2024) |
| Jul 21, 2021 | Dec 1, 2021 | -24.3% | 93 days | 78 days (Mar 24, 2022) |
| Jul 24, 2026 | Oct 1, 2026 | -16.7% | 48 days | Not yet recovered |
| Oct 30, 2024 | Jan 6, 2025 | -14.4% | 45 days | 27 days (Feb 14, 2025) |
| Oct 8, 2020 | Oct 28, 2020 | -13.8% | 14 days | 8 days (Nov 9, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $40.84B
- P/E (TTM)
- 155.6
- EPS, diluted (TTM)
- $0.54
- Revenue (TTM)
- $6.44B
- Dividend yield
- 2.43%
- 52-week range
- $66.93 – $101.60
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.83B | $4.13B | $4.50B | $4.92B | $5.83B |
| Gross profit | $1.74B | $1.85B | $1.94B | $2.10B | -$344.2M |
| Operating income | $421.4M | $483.8M | $415.5M | $681.2M | $826.8M |
| Net income | $49.0M | -$47.4M | -$41.0M | $81.2M | $251.4M |
| EPS (diluted) | $0.13 | -$0.13 | -$0.10 | $0.19 | $0.54 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.24B | $1.29B | $1.36B | $1.42B | $1.49B | $1.57B | $1.66B | $1.73B |
| Net income | $19.2M | $56.8M | $46.9M | $68.3M | $66.0M | $70.2M | $55.9M | $74.1M |
| EPS (diluted) | $0.05 | $0.13 | $0.11 | $0.15 | $0.14 | $0.15 | $0.11 | $0.14 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $1.04B | $1.15B | $1.19B | $1.34B | $1.68B |
| Capital expenditure | -$185.3M | -$222.1M | -$259.4M | -$281.6M | -$363.9M |
| Free cash flow | $858.7M | $926.3M | $935.1M | $1.06B | $1.32B |
| Dividends paid | -$686.9M | -$720.3M | -$723.6M | -$740.3M | -$860.1M |
| Net share buybacks | $625.5M | $7.2M | $109.1M | $1.99B | $2.45B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $199.0M
- Total assets
- $29.66B
- Total liabilities
- $14.44B
- Total debt
- $13.65B
- Net debt
- $13.45B
- Shareholders’ equity
- $14.65B
As of Jun 30, 2026 (filed Jul 30, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 30, 2026 | $0.52 | Oct 15, 2026 |
| Jun 30, 2026 | $0.52 | Jul 16, 2026 |
| Mar 31, 2026 | $0.52 | Apr 16, 2026 |
| Dec 31, 2025 | $0.48 | Jan 15, 2026 |
| Sep 30, 2025 | $0.48 | Oct 16, 2025 |
| Jun 30, 2025 | $0.48 | Jul 17, 2025 |
| Mar 31, 2025 | $0.48 | Apr 17, 2025 |
| Dec 31, 2024 | $0.45 | Jan 16, 2025 |
Short interest
- Shares sold short
- 19,779,274
- Days to cover
- 6.16
- Change vs previous report
- -2.9%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Aug 18, 2015
- 8,757-for-10,000
- Oct 26, 1994
- 3-for-2
- Jan 16, 1992
- 5-for-4
- Jun 18, 1991
- 3-for-2